D. K. Chitkara

798 citations

18 papers · 566 indexed · h-index 10

Co-authors: Filippo Cremonini Michael Camilleri Heiko U. De Schepper Miranda A.L. van Tilburg L. Myasoutova Mazurov Vi Nathan Vastesaeger Joachim Sieper
Topics: Gastrointestinal motility and disorders (7 papers)Gastroesophageal reflux and treatments (5 papers)Spondyloarthritis Studies and Treatments (5 papers)
Cited by: Gastroenterology Rheumatology Pharmacy
Journals: Journal of Clinical Oncology Annals of the Rheumatic Diseases Alimentary Pharmacology & Therapeutics
Partner nations: United States Russia Germany

In The Last Decade

D. K. Chitkara

18 papers receiving 546 citations

Peers

Countries citing papers authored by D. K. Chitkara

Since Specialization

Citations

This map shows the geographic impact of D. K. Chitkara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. K. Chitkara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. K. Chitkara more than expected).

Fields of papers citing papers by D. K. Chitkara

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. K. Chitkara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. K. Chitkara. The network helps show where D. K. Chitkara may publish in the future.

Co-authorship network of co-authors of D. K. Chitkara

This figure shows the co-authorship network connecting the top 25 collaborators of D. K. Chitkara. A scholar is included among the top collaborators of D. K. Chitkara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. K. Chitkara. D. K. Chitkara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	DOP44 Long-term use of ozanimod in patients with moderately to severely active Ulcerative Colitis 2022 ·Journal of Crohn s and Colitis ·Silvio Danese,Jean‐Frédéric Colombel,Terry Ponich,Igor Jovanović,Peter Bossuyt,Randy Longman,(unknown),(unknown),D. K. Chitkara,(unknown),Lorna Charles,David T. Rubin,Anita Afzali,Edward V. Loftus,Douglas C. Wolf	4
2	P315 Population pharmacokinetics and pharmacodynamics of ozanimod in ulcerative colitis 2021 ·Journal of Crohn s and Colitis ·Daniel Tatosian,Jim X Shen,(unknown),(unknown),Nathan S. Teuscher,Sarah Harris,D. K. Chitkara,Giridhar Tirucherai,(unknown)	1
3	OP006 Apremilast for active ulcerative colitis: a phase 2, randomised, double-blind, placebo-controlled induction study 2018 ·Journal of Crohn s and Colitis ·Silvio Danese,Markus F. Neurath,(unknown),Salam Zakko,Timothy Simmons,Ronald Fogel,(unknown),(unknown),Keith Usiskin,D. K. Chitkara	19
4	Adolescents with irritable bowel syndrome report increased eating‐associated symptoms, changes in dietary composition, and altered eating behaviors: a pilot comparison study to healthy adolescents 2016 ·Neurogastroenterology & Motility ·(unknown),(unknown),D. K. Chitkara,Miranda A.L. van Tilburg	60
5	Efficacy and safety of infliximab plus naproxen versus naproxen alone in patients with early, active axial spondyloarthritis: results from the double-blind, placebo-controlled INFAST study, Part 1 2013 ·Annals of the Rheumatic Diseases ·Joachim Sieper,Jan Lenaerts,J. Wollenhaupt,Martín Rudwaleit,Mazurov Vi,L. Myasoutova,(unknown),Yeong Wook Song,(unknown),D. K. Chitkara,Nathan Vastesaeger	147
6	Maintenance of biologic-free remission with naproxen or no treatment in patients with early, active axial spondyloarthritis: results from a 6-month, randomised, open-label follow-up study, INFAST Part 2 2013 ·Annals of the Rheumatic Diseases ·Joachim Sieper,Jan Lenaerts,J. Wollenhaupt,Martín Rudwaleit,Mazurov Vi,L. Myasoutova,(unknown),Yeong Wook Song,(unknown),D. K. Chitkara,Nathan Vastesaeger	42
7	FRI0424 Role of baseline c-reactive protein in response to infliximab plus naproxen vs naproxen alone in patients with axial spondyloarthritis in the infast study 2013 ·Annals of the Rheumatic Diseases ·J. Sieper,Martín Rudwaleit,Jan Lenaerts,J. Wollenhaupt,L. Myasoutova,Sung Soo Park,Yong Sang Song,(unknown),Marcello Govoni,D. K. Chitkara,Nathan Vastesaeger	1
8	THU0274 Double-blind, placebo-controlled, 28-week trial of efficacy and safety of infliximab plus naproxen vs naproxen alone in patients with early, active axial spondyloarthritis treated with a submaximal dose of NSAIDS: Preliminary results of INFAST part I 2012 ·Annals of the Rheumatic Diseases ·Joachim Sieper,Jan Lenaerts,J. Wollenhaupt,Mazurov Vi,L. Myasoutova,S.-H. Park,Yeong Wook Song,(unknown),D. K. Chitkara,Nathan Vastesaeger	4
9	THU0276 A randomized, open-label study to explore whether partial remission can be maintained with naproxen or no treatment in patients with early, active axial spondyloarthritis: Preliminary results of INFAST part II 2012 ·Annals of the Rheumatic Diseases ·Joachim Sieper,(unknown),J. Wollenhaupt,Mazurov Vi,L. Myasoutova,S.-H. Park,Yeong Wook Song,(unknown),D. K. Chitkara,Nathan Vastesaeger	4
10	The effect of a 3-day oral aprepitant regimen on the prevention of CINV over standard therapy in Chinese patients receiving high-dose cisplatin. 2011 ·Journal of Clinical Oncology ·Yufeng Cheng,L. Zhang,(unknown),(unknown),Baohui Han,(unknown),Chi‐Hsien Huang,(unknown),Xian‐Jiang Song,Jun Liang,(unknown),Jia-Qi Hu,(unknown),(unknown),(unknown),(unknown),A. Carides,D. K. Chitkara	2
11	Longitudinal direct medical costs associated with constipation in women 2010 ·Alimentary Pharmacology & Therapeutics ·Rok Seon Choung,Megan E. Branda,D. K. Chitkara,Nilay D. Shah,Slavica K. Katusic,G. Richard Locke,N. J. Talley	42
12	Unexplained Gastrointestinal Symptoms After Abuse in a Prospective Study of Children at Risk for Abuse and Neglect 2010 ·The Annals of Family Medicine ·Miranda A.L. van Tilburg,Desmond K. Runyan,Adam J. Zolotor,J. Christopher Graham,Howard Dubowitz,(unknown),Emalee G. Flaherty,D. K. Chitkara,William E. Whitehead	63
13	The clinical approach to chronic abdominal pain and irritable bowel syndrome in children. 2010 ·PubMed ·Miranda A.L. van Tilburg,D. K. Chitkara	2
14	Pharmacotherapy for functional gastrointestinal disorders in children 2006 ·Current Opinion in Pharmacology ·D. K. Chitkara,Carlo DiLorenzo	7
15	From the bench to the ‘crib’‐side: implications of scientific advances to paediatric neurogastroenterology and motility 2006 ·Neurogastroenterology & Motility ·D. K. Chitkara,Peter L. Lu	14
16	Aerophagia in adults: a comparison with functional dyspepsia 2005 ·Alimentary Pharmacology & Therapeutics ·D. K. Chitkara,Albert J. Bredenoord,Mary Jo Rucker,Nicholas J. Talley	37
17	Aerophagia in children: characterization of a functional gastrointestinal disorder 2005 ·Neurogastroenterology & Motility ·D. K. Chitkara,Albert J. Bredenoord,(unknown),Mary Jo Rucker,Nicholas J. Talley	15
18	Assessment of gastric accommodation: overview and evaluation of current methods 2004 ·Neurogastroenterology & Motility ·Heiko U. De Schepper,Filippo Cremonini,D. K. Chitkara,Michael Camilleri	102

About D. K. Chitkara

D. K. Chitkara is a scholar working on Gastroenterology, Pharmacy and Rheumatology, having authored 18 papers that have together received 566 indexed citations. Recurring topics across this work include Gastrointestinal motility and disorders (7 papers), Gastroesophageal reflux and treatments (5 papers) and Spondyloarthritis Studies and Treatments (5 papers). The work is most often cited by research in Gastroenterology (248 citations), Rheumatology (207 citations) and Pharmacy (47 citations). D. K. Chitkara has collaborated with scholars based in United States, Russia and Germany. Frequent co-authors include Filippo Cremonini, Michael Camilleri, Heiko U. De Schepper, Miranda A.L. van Tilburg, L. Myasoutova, Mazurov Vi, Nathan Vastesaeger, Joachim Sieper, Jan Lenaerts and Yeong Wook Song. Their work appears in journals such as Journal of Clinical Oncology, Annals of the Rheumatic Diseases and Alimentary Pharmacology & Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact